Acute Myeloid Leukemia
📧 Sign up to get email alerts when something new happens for Acute Myeloid Leukemia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-07-19Clinical Trial Update: Allogeneic Stem Cell Transplant With Clofarabine, Busulfan and Antithymocyte Globulin (ATG) for Adult Patients With High-risk Acute Myeloid Leukemia/Myelodysplastic Syndromes (AML/MDS) or Acute Lymphoblastic Leukemia (ALL) [Phase 2]
Phase 2 trial evaluating an allogeneic stem cell transplant regimen combining clofarabine, busulfan, and antithymocyte globulin in adults wi…
-
CLINICAL_TRIALS trial_result · 2017-07-17Clinical Trial Update: Preservation of Ovarian Function After Hematopoietic Cell Transplant [Phase 2]
Phase 2 trial investigating preservation of ovarian function after hematopoietic cell transplantation in patients with hematologic cancers; …
-
CLINICAL_TRIALS trial_result · 2017-07-17Clinical Trial Update: PKC412 in Participants With Acute Myeloid Leukemia or With Myelodysplastic Syndrome (CPKC412A2104 Core); and PKC412 in Participants With Acute Myeloid Leukemia or With Myelodysplastic Syndrome With Either Wild Type or Mutated FMS-like Tyrosine Kinase 3 (FLT3) (CPKC412A2104E1 and CPKC412A2104E2) [Phase 1, Phase 2]
This clinical trial update reports the completion and posted results of Phase 1 and Phase 2 studies of PKC412 (midostaurin) in adults with a…
-
CLINICAL_TRIALS trial_result · 2017-07-13Clinical Trial Update: Busulfan/Clofarabine + Allogeneic Stem Cell Transplantation [Phase 2]
This Phase 2 clinical trial update reports results for busulfan and clofarabine conditioning followed by allogeneic stem cell transplantatio…
-
CLINICAL_TRIALS trial_result · 2017-07-11Clinical Trial Update: Post Transplant Donor Lymphocyte Infusion [Phase 2]
Phase 2 clinical trial update for post-transplant donor lymphocyte infusion; the study is terminated with results posted in 2017.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-07-11Clinical Trial Update: Clofarabine and Cytarabine in Treating Older Patients With AML or High-Risk MDS [Phase 1, Phase 2]
Clinical trial update of a Phase 1/2 study evaluating the combination of clofarabine and cytarabine in older patients with acute myeloid leu…
-
CLINICAL_TRIALS trial_result · 2017-07-07Clinical Trial Update: An Extension Study of RO5045337 in Participants Participating in Previous Roche-sponsored Cancer Studies [Phase 1]
Hoffmann-La Roche announced completion of an extension study for RO5045337 in participants from previous Roche cancer studies, involving chr…
-
CLINICAL_TRIALS trial_result · 2017-07-02Clinical Trial Update: Fludarabine Phosphate, Melphalan, and Low-Dose Total-Body Irradiation Followed by Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies [Phase 2]
Phase 2 trial evaluating fludarabine phosphate, melphalan, and low-dose total-body irradiation followed by donor peripheral blood stem cell …
-
CLINICAL_TRIALS trial_result · 2017-07-02Clinical Trial Update: Efficacy Study of Inecalcitol With Decitabine in Acute Myeloid Leukemia Patients Unfit for Standard Chemotherapy [Phase 2]
A Phase 2 clinical trial evaluating the efficacy of combining inecalcitol with decitabine in acute myeloid leukemia patients who are unfit f…
-
CLINICAL_TRIALS trial_result · 2017-07-02Clinical Trial Update: Cyclosporine, Pravastatin Sodium, Etoposide, and Mitoxantrone Hydrochloride in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia [Phase 1, Phase 2]
Phase 1/2 clinical trial update evaluating cyclosporine, pravastatin sodium, etoposide, and mitoxantrone hydrochloride in relapsed or refrac…
-
CLINICAL_TRIALS trial_result · 2017-06-29Clinical Trial Update: CNDO-109-AANK for AML in First Complete Remission (CR1) [Phase 1, Phase 2]
This clinical trial update covers CNDO-109-AANK for acute myeloid leukemia in first complete remission (CR1) in Phase 1/Phase 2, with result…
-
CLINICAL_TRIALS trial_result · 2017-06-28Clinical Trial Update: Study of Voreloxin (Vosaroxin) in Older Patients With Untreated Acute Myeloid Leukemia [Phase 2]
Phase 2 results update for Vosaroxin (Voreloxin) in older patients with untreated acute myeloid leukemia; results were posted in 2017.
-
CLINICAL_TRIALS trial_result · 2017-06-28Clinical Trial Update: Trial of Eltrombopag During Consolidation Therapy in Adults With AML in Complete Remission [Phase 1, Phase 2]
A phase 1/2 trial evaluating eltrombopag during consolidation therapy in adults with acute myeloid leukemia in complete remission; the study…
-
CLINICAL_TRIALS trial_result · 2017-06-26Clinical Trial Update: Safety and Efficacy of 72-hour and 120-hour Infusion of Rigosertib in Acute Myeloid Leukemia (AML) and Acute Lymphoid Leukemia (ALL) [Phase 1, Phase 2]
Clinical trial update reporting safety and efficacy results for 72-hour and 120-hour infusions of rigosertib in acute myeloid leukemia and a…
-
CLINICAL_TRIALS trial_result · 2017-06-26Clinical Trial Update: Study of 72-Hour Infusion of ON 01910.Na in Patients With MDS or AML [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating a 72-hour infusion of ON 01910.Na in patients with myelodysplastic syndromes or acute myeloid leukemia…
-
CLINICAL_TRIALS trial_result · 2017-06-14Clinical Trial Update: Donor-derived Anti-CD123-CART Cells for Recurred AML After Allo-HSCT [Phase 1]
This clinical trial update describes a Phase 1 study evaluating donor-derived anti-CD123 CAR T cells for relapse of acute myeloid leukemia a…
-
CLINICAL_TRIALS trial_result · 2017-06-14Clinical Trial Update: Fludarabine Based Conditioning for Allogeneic Transplantation for Advanced Hematologic Malignancies [NA]
Clinical trial update for fludarabine-based conditioning prior to allogeneic transplantation in advanced hematologic malignancies; study com…
-
CLINICAL_TRIALS trial_result · 2017-06-08Clinical Trial Update: Observational Trial of a Therapeutic Platelet Transfusion Regimen
An observational trial evaluating a therapeutic platelet transfusion regimen for patients with acute myeloid leukemia and thrombocytopenia h…
-
CLINICAL_TRIALS trial_result · 2017-06-06Clinical Trial Update: Alvocidib, Cytarabine, and Mitoxantrone Hydrochloride or Cytarabine and Daunorubicin Hydrochloride in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia [Phase 2]
Phase 2 trial evaluating alvocidib with cytarabine and mitoxantrone or cytarabine and daunorubicin in adults with newly diagnosed acute myel…
-
CLINICAL_TRIALS trial_result · 2017-06-06Clinical Trial Update: Study Evaluating AMD3100 for Transplantation of Sibling Donor Stem Cells in Patients With Hematological Malignancies [Phase 1, Phase 2]
Phase 1/2 study evaluating plerixafor (AMD3100) as a stem cell mobilizer for transplantation from a sibling donor in various hematologic mal…
-
CLINICAL_TRIALS trial_result · 2017-06-05Clinical Trial Update: Busulfan and Etoposide Followed by Peripheral Blood Stem Cell Transplant and Low-Dose Aldesleukin in Treating Patients With Acute Myeloid Leukemia [Phase 2]
Phase 2 trial evaluating a conditioning regimen of busulfan and etoposide followed by peripheral blood stem cell transplant with low-dose al…
-
CLINICAL_TRIALS trial_result · 2017-06-05Clinical Trial Update: Consolidation Therapy for Acute Myeloid Leukemia Guided by Leukemia Stem Cell Behavior [Phase 2, Phase 3]
A phase 2/3 trial on consolidation therapy for acute myeloid leukemia guided by leukemia stem cell behavior; trial terminated with results p…
-
CLINICAL_TRIALS trial_result · 2017-06-01Clinical Trial Update: Vorinostat and Gemtuzumab Ozogamicin in Treating Older Patients With Previously Untreated Acute Myeloid Leukemia [Phase 2]
Phase 2 trial update evaluating vorinostat with gemtuzumab ozogamicin in older patients with previously untreated acute myeloid leukemia. Th…
-
CLINICAL_TRIALS trial_result · 2017-05-30Clinical Trial Update: Alemtuzumab, Fludarabine Phosphate, and Total-Body Irradiation Followed by Cyclosporine and Mycophenolate Mofetil in Treating Patients Who Are Undergoing Donor Stem Cell Transplant for Hematologic Cancer [Phase 2]
Phase 2 trial evaluating a conditioning regimen with alemtuzumab, fludarabine phosphate, and total-body irradiation followed by cyclosporine…
-
CLINICAL_TRIALS trial_result · 2017-05-30Clinical Trial Update: Healing Touch in Treating Patients Receiving Chemotherapy for Acute Myeloid Leukemia or Acute Lymphocytic Leukemia [NA]
A completed clinical trial evaluating Healing Touch as an adjunct for patients receiving chemotherapy for acute myeloid leukemia or acute ly…